"Mutation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
| Descriptor ID |
D009154
|
| MeSH Number(s) |
G05.365.590
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mutation".
Below are MeSH descriptors whose meaning is more specific than "Mutation".
This graph shows the total number of publications written about "Mutation" by people in this website by year, and whether "Mutation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 12 | 18 | 30 |
| 1997 | 15 | 37 | 52 |
| 1998 | 23 | 23 | 46 |
| 1999 | 22 | 48 | 70 |
| 2000 | 19 | 53 | 72 |
| 2001 | 21 | 48 | 69 |
| 2002 | 21 | 62 | 83 |
| 2003 | 32 | 65 | 97 |
| 2004 | 30 | 68 | 98 |
| 2005 | 31 | 85 | 116 |
| 2006 | 26 | 81 | 107 |
| 2007 | 41 | 82 | 123 |
| 2008 | 36 | 65 | 101 |
| 2009 | 39 | 70 | 109 |
| 2010 | 27 | 73 | 100 |
| 2011 | 39 | 98 | 137 |
| 2012 | 44 | 82 | 126 |
| 2013 | 37 | 97 | 134 |
| 2014 | 68 | 107 | 175 |
| 2015 | 72 | 111 | 183 |
| 2016 | 78 | 97 | 175 |
| 2017 | 75 | 135 | 210 |
| 2018 | 75 | 134 | 209 |
| 2019 | 66 | 130 | 196 |
| 2020 | 43 | 166 | 209 |
| 2021 | 42 | 133 | 175 |
| 2022 | 3 | 130 | 133 |
| 2023 | 3 | 106 | 109 |
| 2024 | 34 | 90 | 124 |
| 2025 | 33 | 99 | 132 |
| 2026 | 10 | 46 | 56 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mutation" by people in Profiles.
-
Therapy-Related Mutational Signatures in Subsequent Neoplasms among Survivors of Childhood Cancer. Cancer Discov. 2026 Aug 03; 16(8):1590-1610.
-
Baseline and placebo-related imaging, cerebrospinal fluid, plasma biomarker, and cognitive findings in unimpaired PSEN1 E280A mutation carriers and non-carriers in the Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia Trial. EBioMedicine. 2026 Aug; 130:106390.
-
Divergent biology and outcomes of somatic transformations in germ cell tumors. Oncologist. 2026 Jul 08; 31(8).
-
Neurodevelopmental Phenotypes and Brain Anomalies in Individuals With Heterozygous SEMA6A Variants. Clin Genet. 2026 Sep; 110(3):325-335.
-
Genetics of Cerebrotendinous Xanthomatosis. Mol Diagn Ther. 2026 Jul; 30(4):681-687.
-
Biomarker study of pembrolizumab in patients with advanced rare cancers. Cell Rep Med. 2026 Jun 16; 7(6):102827.
-
Biallelic ARID1A Alterations : A Promising Novel Biomarker for Risk Stratification and Management in Pediatric Malignant Hepatocellular Tumors. Am J Surg Pathol. 2026 Sep 01; 50(9):1106-1119.
-
Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets. Nat Cancer. 2026 Jun; 7(6):993-1015.
-
Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing. Nat Commun. 2026 Jun 11; 17(1).
-
Single-nucleus profiling reveals a core disease signature and cell type-specific vulnerabilities in early Rett syndrome. Sci Adv. 2026 Jun 12; 12(24):eaeb4265.